Healthcare provider profile · identity verified

Kelsi K. Nelson, M.D.

Family Practice · MINNEAPOLIS, MN · NPI 1992733976

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Warfarin Sodium	Warfarin Sodium	804	29
Gabapentin	Gabapentin	566	63
Levothyroxine Sodium	Levothyroxine Sodium	469	58
Furosemide	Furosemide	428	62
Atorvastatin Calcium	Atorvastatin Calcium	404	62
Eliquis	Apixaban	392	50
Jantoven	Warfarin Sodium	321	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	284	26
Pantoprazole Sodium	Pantoprazole Sodium	279	35
Losartan Potassium	Losartan Potassium	270	34
Lisinopril	Lisinopril	258	36
Duloxetine Hcl	Duloxetine Hcl	257	28
Tamsulosin Hcl	Tamsulosin Hcl	250	38
Potassium Chloride	Potassium Chloride	243	42
Metoprolol Succinate	Metoprolol Succinate	238	46
Sertraline Hcl	Sertraline Hcl	237	31
Quetiapine Fumarate	Quetiapine Fumarate	221	20
Omeprazole	Omeprazole	192	44
Metformin Hcl	Metformin Hcl	183	26
Mirtazapine	Mirtazapine	175	26
Metoprolol Tartrate	Metoprolol Tartrate	174	27
Trazodone Hcl	Trazodone Hcl	157	20
Spironolactone	Spironolactone	154	20
Clopidogrel	Clopidogrel Bisulfate	151	20
Amlodipine Besylate	Amlodipine Besylate	145	31
Famotidine	Famotidine	137	21
Citalopram Hbr	Citalopram Hydrobromide	132	21
Torsemide	Torsemide	131	21
Xarelto	Rivaroxaban	124	suppressed
Baclofen	Baclofen	120	suppressed
Prednisone	Prednisone	120	19
Albuterol Sulfate	Albuterol Sulfate	110	31
Simvastatin	Simvastatin	106	17
Carvedilol	Carvedilol	105	11
Escitalopram Oxalate	Escitalopram Oxalate	90	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	87	13
Januvia	Sitagliptin Phosphate	87	suppressed
Latanoprost	Latanoprost	87	20
Olanzapine	Olanzapine	86	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	84	17
Levetiracetam	Levetiracetam	82	suppressed
Montelukast Sodium	Montelukast Sodium	78	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	74	suppressed
Finasteride	Finasteride	70	suppressed
Hydralazine Hcl	Hydralazine Hcl	69	suppressed
Nystatin	Nystatin	68	36
Buspirone Hcl	Buspirone Hcl	64	suppressed
Diclofenac Sodium	Diclofenac Sodium	62	13
Metformin Hcl Er	Metformin Hcl	58	suppressed
Klor-Con M20	Potassium Chloride	52	suppressed
Donepezil Hcl	Donepezil Hcl	51	suppressed
Propranolol Hcl	Propranolol Hcl	50	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	15
Sodium Chloride	Sodium Chloride Irrig Solution	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Atenolol	Atenolol	47	suppressed
Divalproex Sodium	Divalproex Sodium	46	suppressed
Bupropion Xl	Bupropion Hcl	45	suppressed
Digoxin	Digoxin	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Cephalexin	Cephalexin	43	16
Divalproex Sodium Er	Divalproex Sodium	43	suppressed
Bumetanide	Bumetanide	42	suppressed
Carbamazepine	Carbamazepine	40	suppressed
Allopurinol	Allopurinol	39	14
Memantine Hcl	Memantine Hcl	39	suppressed
Midodrine Hcl	Midodrine Hcl	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Lamotrigine	Lamotrigine	35	suppressed
Loperamide	Loperamide Hcl	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Lidocaine	Lidocaine	34	suppressed
Hydrocortisone	Hydrocortisone	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Klor-Con M10	Potassium Chloride	32	suppressed
Sucralfate	Sucralfate	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	16
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Lorazepam	Lorazepam	28	suppressed
Risperidone	Risperidone	28	suppressed
Trintellix	Vortioxetine Hydrobromide	28	suppressed
Trospium Chloride	Trospium Chloride	28	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Ketoconazole	Ketoconazole	26	11
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	25	25
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Entresto	Sacubitril/Valsartan	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Timolol Maleate	Timolol Maleate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Clotrimazole	Clotrimazole	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Glipizide	Glipizide	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Topiramate	Topiramate	19	suppressed
Budesonide	Budesonide	18	suppressed
Lanthanum Carbonate	Lanthanum Carbonate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	17	suppressed
Primidone	Primidone	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cyclosporine	Cyclosporine	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Metolazone	Metolazone	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Nyamyc	Nystatin	15	suppressed
Cromolyn Sodium	Cromolyn Sodium	14	suppressed
Linzess	Linaclotide	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Asmanex	Mometasone Furoate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Restasis	Cyclosporine	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	12	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error